← Leaderboards
Eveline Barbieri
Baylor College Of Medicine
$2,823,035
Attributed
$2,823,035
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $763.4K · FY2019–25$1M$750K$500K$250K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,823,035 · 3
By mechanism
R01$2,597,934 · 2
R21$225,101 · 1
Top collaborators
No co-investigators on record.
Most similar at Baylor College Of Medicine
Same institution · by research overlap
- Jianhua Yang$4,705,917
- Peter E. Zage$1,722,994
- Xiaoliu Zhang$8,408,799
- Jianpeng Ma$4,738,159
- Zhaoyong Hu$3,424,065
Others in their field
Other Emerging Leaders on “Automobile Driving”
- Yunda Huang · Fred Hutchinson Cancer Center$52,003,716
- Susan Abushakra · Alzheon, Inc.$47,690,244
- Scott Topper · Broad Institute, Inc.$30,147,501
- Leonard Freedman · Leidos Biomedical Research, Inc.$15,624,898
- Ganesh M Babulal · Washington University$11,062,209
- Christopher A. Gaiteri · Rush University Medical Center$9,886,289
Research focus
Automobile DrivingPhenotypeRegulationTumor MetabolismTumorTherapy ResistantMalignant NeoplasmsMetabolismTumorigenesisProgramsGeneticTretinoinGrowthCellular Metabolic ProcessLiteratureMalignant Childhood NeoplasmChildMetabolicMolecularNeuroblastomaPathway InteractionsSignal TransductionNeural CrestRecruit
Grant awards (9)
Rewired Metabolism and Immunosuppression in MYCN-driven Neuroblastoma$418,553
R01 · FY2025 · CA · contact PI
MYCN drives a suppressive tumor immune microenvironment in neuroblastoma.$225,101
R21 · FY2025 · CA · contact PI
Rewired Metabolism and Immunosuppression in MYCN-driven Neuroblastoma$431,968
R01 · FY2024 · CA · contact PI
Towards Novel Differentiation Therapies for Neuroblastoma.$331,444
R01 · FY2024 · CA · contact PI
Towards Novel Differentiation Therapies for Neuroblastoma.$341,909
R01 · FY2023 · CA · contact PI
Towards Novel Differentiation Therapies for Neuroblastoma.$348,888
R01 · FY2022 · CA · contact PI
Towards Novel Differentiation Therapies for Neuroblastoma.$1
R01 · FY2021 · CA · contact PI
Towards Novel Differentiation Therapies for Neuroblastoma.$359,176
R01 · FY2020 · CA · contact PI
Towards Novel Differentiation Therapies for Neuroblastoma.$365,995
R01 · FY2019 · CA · contact PI